| 001 | 20285 | ||
| 005 | 20200402210217.0 | ||
| 024 | 7 | _ | |2 DOI |a 10.2174/138161212799277752 |
| 024 | 7 | _ | |a altmetric:21807820 |2 altmetric |
| 037 | _ | _ | |a PreJuSER-20285 |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Funke, S.A. |b 0 |u FZJ |0 P:(DE-Juel1)VDB101069 |
| 245 | _ | _ | |a Peptides for Therapy and Diagnosis of Alzheimer' s Disease |
| 260 | _ | _ | |a Hilversum |b Bentham Science Publ. |c 2012 |
| 300 | _ | _ | |a 755 - 767 |
| 336 | 7 | _ | |a Journal Article |0 PUB:(DE-HGF)16 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a article |2 DRIVER |
| 440 | _ | 0 | |a Current Pharmaceutical Design |x 1381-6128 |0 7901 |y 6 |v 18 |
| 500 | _ | _ | |a Record converted from VDB: 12.11.2012 |
| 536 | _ | _ | |a Funktion und Dysfunktion des Nervensystems |c P33 |2 G:(DE-HGF) |0 G:(DE-Juel1)FUEK409 |x 0 |
| 536 | _ | _ | |a BioSoft: Makromolekulare Systeme und biologische Informationsverarbeitung |c P45 |0 G:(DE-Juel1)FUEK505 |x 1 |
| 700 | 1 | _ | |a Willbold, D. |b 1 |u FZJ |0 P:(DE-Juel1)132029 |
| 773 | _ | _ | |a 10.2174/138161212799277752 |g Vol. 18, p. 755 - 767 |p 755 - 767 |q 18<755 - 767 |0 PERI:(DE-600)2034245-7 |t Current pharmaceutical design |v 18 |y 2012 |x 1381-6128 |
| 856 | 7 | _ | |u http://dx.doi.org/10.2174/138161212799277752 |
| 909 | C | O | |o oai:juser.fz-juelich.de:20285 |p VDB |
| 913 | 1 | _ | |b Gesundheit |k P33 |l Funktion und Dysfunktion des Nervensystems |1 G:(DE-HGF)POF2-330 |0 G:(DE-Juel1)FUEK409 |2 G:(DE-HGF)POF2-300 |v Funktion und Dysfunktion des Nervensystems |x 0 |
| 913 | 1 | _ | |b Schlüsseltechnologien |k P45 |l Biologische Informationsverarbeitung |1 G:(DE-HGF)POF2-450 |0 G:(DE-Juel1)FUEK505 |2 G:(DE-HGF)POF2-400 |v BioSoft: Makromolekulare Systeme und biologische Informationsverarbeitung |x 1 |
| 913 | 2 | _ | |a DE-HGF |b Key Technologies |l BioSoft Fundamentals for future Technologies in the fields of Soft Matter and Life Sciences |1 G:(DE-HGF)POF3-550 |0 G:(DE-HGF)POF3-553 |2 G:(DE-HGF)POF3-500 |v Physical Basis of Diseases |x 0 |
| 914 | 1 | _ | |y 2012 |
| 915 | _ | _ | |a JCR/ISI refereed |0 StatID:(DE-HGF)0010 |2 StatID |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0110 |2 StatID |b Science Citation Index |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0111 |2 StatID |b Science Citation Index Expanded |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Thomson Reuters Master Journal List |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0310 |2 StatID |b NCBI Molecular Biology Database |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1120 |2 StatID |b BIOSIS Reviews Reports And Meetings |
| 920 | 1 | _ | |k ICS-6 |l Strukturbiochemie |g ICS |0 I:(DE-Juel1)ICS-6-20110106 |x 0 |
| 970 | _ | _ | |a VDB:(DE-Juel1)135594 |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a ConvertedRecord |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a I:(DE-Juel1)ICS-6-20110106 |
| 980 | _ | _ | |a UNRESTRICTED |
| 981 | _ | _ | |a I:(DE-Juel1)IBI-7-20200312 |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|